NPI registry status
Active
2026 NPPES data Child & Adolescent Psychiatry Physician NPI 1457491375 M.D.
Verify on CMS → Mark Sands, M.D.
Child & Adolescent Psychiatry Physician in Metairie, Louisiana.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 6,160 in Child & Adolescent Psychiatry Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 41 beneficiaries · Child & Adolescent Psychiatry Physician avg: 600
Generic prescribing
95%
generic claims · 5% brand-name · higher generic rates reduce patient out-of-pocket costs
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Mark Sands, M.D. filed 1,045 Medicare Part D claims in 2023 as a Child & Adolescent Psychiatry Physician in Metairie, Louisiana, prescribing 95% generic.
- 1K
- Part D claims, 2023
- 95%
- generic prescribing
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Mark Sands, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
1,045 Top 24% higher than 76% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
◑
Board-eligible specialty (heuristic, not verified)
Mark Sands, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mark Sands, M.D.?
Quality data not reportedPrimary specialty
Child & Adolescent Psychiatry Physician
Medicare Part D claims
1,045 74% vs specialty avg
Specialty distribution in Louisiana
How Child & Adolescent Psychiatry Physician compares to other specialties among Louisiana providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Child & Adolescent Psychiatry Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Mark Sands, M.D. appears in the CMS NPPES registry as a Child & Adolescent Psychiatry Physician provider holding M.D. credentials at 110 VETERANS MEMORIAL BLVD, Metairie, LA, 70005, with a listed phone of (504) 838-8283. NPI 1457491375 was issued on 02/08/2007.
Medicare Part D records for calendar year 2023 show 1,045 prescription claims written by this provider, covering 41 Medicare beneficiaries and totaling roughly $81K in drug spend, split 5% brand-name and 95% generic by claim count.
Child & Adolescent Psychiatry Physician is a mid-sized specialty nationwide, with 6,160 enrolled providers across 54 states and an average of 600 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1457491375 |
|---|---|
| Specialty | Child & Adolescent Psychiatry Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 02/08/2007 |
Brand vs generic prescribing mix · Generic-heavy
Mark Sands, M.D. - brand share 5.0%
Child & Adolescent Psychiatry Physician average
5% brand-name claims vs 95% generic, on 1,045 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,045
Total Claims
$81K
Total Drug Cost
41
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,436
- Total Day Supply
- 42,393
- Brand vs Generic
- 5% brand / 95% generic
- Brand Drug Cost
- $59K
- Generic Drug Cost
- $22K
Patient Demographics
- Average Patient Age
- 44.6 years
- Avg HCC Risk Score
- 0.75
- Gender Split
- 46% female / 54% male
- Age Distribution
- <65: 29, 65-74: N/A, 75-84: N/A, 85+: 0
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Mark Sands, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Quetiapine Fumarate
Quetiapine Fumarate
111 claims
- Clonazepam
Clonazepam
90 claims
- Fluoxetine Hcl
Fluoxetine Hcl
65 claims
- Ziprasidone Hcl
Ziprasidone Hcl
65 claims
- Trazodone Hcl
Trazodone Hcl
57 claims
- Lorazepam
Lorazepam
48 claims
- Risperidone 41
Risperidone
41 claims
- Clonidine Hcl 38
Clonidine Hcl
38 claims
| Drug | Claims |
|---|---|
| Quetiapine Fumarate | 111 |
| Clonazepam | 90 |
| Fluoxetine Hcl | 65 |
| Ziprasidone Hcl | 65 |
| Trazodone Hcl | 57 |
| Lorazepam | 48 |
| Risperidone | 41 |
| Clonidine Hcl | 38 |
| Escitalopram Oxalate | 28 |
| Topiramate | 28 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Child & Adolescent Psychiatry Physician in LA →
All providers in Louisiana →
Compare specialties →
Child & Adolescent Psychiatry Physician Overview
How Mark Sands, M.D. fits within the Child & Adolescent Psychiatry Physician landscape nationally.
6,160
Child & Adolescent Psychiatry Physician Providers in US
54
States with Child & Adolescent Psychiatry Physician
600
Avg Claims per Provider
Mark Sands, M.D.'s 1,045 claims are above the specialty average of 600.
Nearby Child & Adolescent Psychiatry Physician Providers in Louisiana
Other clinicians with the same primary specialty enrolled in Louisiana, drawn from the same CMS NPPES roster as Sands.
Dr. Isfana Ali
M.D.
Mandeville, LA
Dr. Milton Anderson
MD
New Orleans, LA
Josefina Baltazar
Hammond, LA
Dr. Cheryll Bowers-Stephens
M.D.
New Orleans, LA
Dr. Renee Bruno
M.D.
Baton Rouge, LA
Compare Child & Adolescent Psychiatry Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Louisiana medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Child & Adolescent Psychiatry Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Louisiana
Frequently Asked Questions
What is Mark Sands, M.D.'s specialty? ▼
Mark Sands, M.D. specializes in Child & Adolescent Psychiatry Physician and practices in Metairie, Louisiana. Credentials: M.D..
How much does Mark Sands, M.D. prescribe under Medicare Part D? ▼
In 2023, Mark Sands, M.D. wrote 1,045 Medicare Part D claims totaling $81K in drug costs for 41 beneficiaries.
Where is Mark Sands, M.D. located? ▼
Mark Sands, M.D. is located at 110 VETERANS MEMORIAL BLVD, Metairie, LA, 70005. Phone: (504) 838-8283.
What is Mark Sands, M.D.'s NPI number? ▼
Mark Sands, M.D.'s National Provider Identifier (NPI) is 1457491375, issued on 02/08/2007.
Does Mark Sands, M.D. prescribe more brand-name or generic drugs? ▼
Mark Sands, M.D.'s prescribing is 5% brand-name and 95% generic drugs by claim count, with $59K in brand drug costs.
How many Child & Adolescent Psychiatry Physician providers are there in the US? ▼
There are 6,160 Child & Adolescent Psychiatry Physician providers across 54 states in the US. The average Child & Adolescent Psychiatry Physician provider writes 600 Medicare Part D claims per year.
What drugs does Mark Sands, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Mark Sands, M.D.'s most frequently prescribed drugs include Quetiapine Fumarate, Clonazepam, Fluoxetine Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mark Sands, M.D. accept Medicare? ▼
Mark Sands, M.D. appears in CMS Medicare data with 1,045 Part D claims and 41 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mark Sands, M.D.'s credentials? ▼
Mark Sands, M.D.'s NPI is 1457491375 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.